Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,495,089.00
Jul 1, 2016
Towards new therapeutics through manipulation of glyco-enzymes
$100,000.00
Jul 1, 2016
Role of Post-Synaptic Density Proteins in the Integration of Dopamine and Glutamate Receptor Functions
$4,035,752.00
Jul 1, 2016
Controlling neural networks essential for memory to gain new insights into novel interventions for memory loss
$133,132.00
Jul 1, 2016
Computational methods and databases to identify small RNA-binding molecules regulating gene expression.
$2,436,900.00
Jul 1, 2016
Investigating the contribution of stroma to kidney health and disease.
$925,045.00
Jul 1, 2016
ShcA-coupled receptor tyrosine kinase signaling exposes PGC1a-dependent metabolic vulnerabilities in cancer progression and therapy
$699,520.00
Jul 1, 2016
The molecular heritage of vascular injury: Roles in rejection and renal failure
$955,625.00
Jul 1, 2016
Development of small RNAs for HIV-1 gene and drug therapy
$1,330,231.00
Jul 1, 2016
Investigating Parkinson disease-linked genes in brain health following infections.
$363,137.00
Jul 1, 2016
Understanding HIV-mediated innate immune dysregulation: the role of the immune inhibitory protein LAG-3